Target intelligence / Profile preview

Fibronectin type III domain-containing protein 8 (FNDC8)

Target
FNDC8
Molecular classification
Other (specifically, a member of the fibronectin type III domain-containing protein family), Not classified as a receptor, enzyme, ion channel, transporter, or transcription factor
01

Overview

Fibronectin type III domain-containing protein 8 (FNDC8) is a protein-coding gene belonging to the FNDC family, distinguished by the presence of one or more fibronectin type III domains, typically implicated in protein-protein interactions and structural functions in cells[3][6]. FNDC8 is highly expressed in the testis and is specifically localized to the perinuclear theca of developing and mature spermatozoa, where it interacts with notable structural proteins such as CCIN and ACTL7A, playing an essential role in sperm head shaping and proper acrosome anchoring[1]. Knockout studies in mice have demonstrated that the absence of FNDC8 leads to male infertility due to aberrations in sperm morphology and defective spermatogenesis[1]. Its role outside of testicular development is not well characterized, and FNDC8 is not currently a known target for therapeutic intervention[2][3][6]. The gene is catalogued in major biological databases and is sometimes mentioned in high-throughput studies of cancer/biomarker gene expression, but direct links to disease other than infertility have not been established[2][3].

Other names
FNDC8Fibronectin type III domain containing 8DKFZp434H2215Fndc8 (mouse homolog)
02

Mechanism of action

Not applicable, as no drugs are known to interact with the protein.

03

Biological functions

Spermatogenesis (including sperm head shaping and acrosome anchoring)May contribute to chromatin integrity and flagellum biogenesis in spermLikely functions as a structural component of the perinuclear theca region of mature spermatozoaWidely expressed at the mRNA level in certain tissues; functions outside testis are less defined
04

Disease associations

Infertility (male infertility due to abnormal spermatogenesis, supported by knockout mouse models)Possible (but unproven) association with tumor biology (not specific, family-level only)Inherited cancer-predisposing syndrome (listed as associated in genetic databases, but with no direct mechanistic or clinical evidence)
05

Biomarkers

Reduced mRNA expression in certain cancers; potential as a prognostic biomarker in cancer, but evidence remains preliminary and based on expression data onlyNo protein-level or clinical biomarker applications identified.

Beyond the preview

Go deeper on Fibronectin type III domain-containing protein 8 (FNDC8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fibronectin type III domain-containing protein 8 (FNDC8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call